Document ID: chunk:federal_register_of_legislation:F2024L01746:clause:2_1
Version: federal_register_of_legislation:F2024L01746
Segment Type: clause
Provision Reference: sch 2 cl 1
Character Range: 11401–11971

1  Schedule 1 (table)
Omit:
Abacavir with lamivudine  Tablet containing abacavir 600 mg (as sulfate) with lamivudine 300 mg  Oral  Abacavir/Lamivudine Viatris  after 31 December 2024—4 months stock by reference to usual demand of both Abacavir/Lamivudine Viatris and Abacavir/Lamivudine Mylan added together
Acamprosate               Tablet (enteric coated) containing acamprosate calcium 333 mg          Oral  Acamprosate Viatris          after 30 July 2024—4 months stock by reference to usual demand of both Acamprosate Viatris and Acamprosate Mylan added together